Theriva Biologics

VCN-01 Plus Chemotherapy Receives FDA Orphan Drug Designation for Early PDAC Treatment

Source – Theriva Biologics On 28June 2023, the FDA has granted Orphan Drug Designation (ODD) to VCN-01 in combination with ...